Cabergoline as an adjuvant to standard heart failure treatment in peripartum cardiomyopathy: A case report and review of the literature
Introduction: Peripartum cardiomyopathy (PPCM) is a rare and idiopathic form of dilated cardiomyopathy presenting late in pregnancy or early postpartum. Since the 16-kDa fragment of prolactin has been identified as a key factor in the pathophysiology of PPCM, prolactin inhibitors have been used as a...
Saved in:
Main Authors: | Giuseppe Caruso (Author), Annalisa Scopelliti (Author), Sara Scaramuzzino (Author), Giuseppina Perrone (Author), Paola Galoppi (Author), Innocenza Palaia (Author), Ludovico Muzii (Author), Pierluigi Benedetti Panici (Author), Roberto Brunelli (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cabergoline in the Treatment of Peripartum Cardiomyopathy
by: James D. Fett
Published: (2016) -
Vulvar Malignancy in Neurofibromatosis Syndrome
by: Angela Musella, et al.
Published: (2013) -
The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study
by: Violante Di Donato, et al.
Published: (2022) -
Peripartum Cardiomyopathy Presenting as Bradycardia
by: Elisabeth Codsi, et al.
Published: (2017) -
Peripartum cardiomyopathy: a review
by: Capriola M
Published: (2012)